HIV and AIDS Trial, Recruiting NCT05398185 Sponsor: Columbia University Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05398185
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • You must be able to speak, read, and write in Spanish
  • You must be 18 years old or older
  • You must be willing to take part in whichever group of the study you are assigned to
  • You must have an HIV-1 viral load (the amount of HIV in your blood) above 50 copies/mL, meaning the virus is not fully controlled
  • You must own a smartphone (note: if you are in the Dominican Republic part of the study and don't have one, the study may provide you with one)
  • You must be willing and able to give your consent to participate and allow the study team to access your medical records

Who may not be able to join:

  • You currently live in a nursing home, prison, or are receiving inpatient psychiatric care
  • You have a serious illness where doctors expect you may have less than 6 months to live
  • You are planning to move away from the study area within the next 12 months
  • You do not meet a minimum score on a short memory and thinking test (called the Mini-Mental State Examination), which checks that you are aware of basic things like the time and where you are (confirm with trial site)
  • You are the spouse or partner of someone already enrolled in the study, or someone else from your household is already participating — only one person per family or household may join

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rebecca Schnall, PhD, MPH, Columbia University

Phone: 212-342-6886

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
1 November 2026

Where this trial is recruiting

Dominican Republic 🇺🇸 United States

Primary endpoints

Change in self-reported ART adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov